A Phase I/II study of vesigenurtacel-l (hs-410) or placebo in combination with Bacillus Calmette-Guérin (BCG) in patients with non-muscle invasive bladder cancer (NMIBC)

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014

Altmetric Badge

Citations

So far, Dimensions has found 3 publications that cite this research output.

Article in Expert Opinion on Biological Therapy (May 2022)

Article in Current Urology Reports (October 2018)

Article in Drug Design Development and Therapy (October 2016)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.